Short term effectiveness of ustekinumab versus vedolizumab in Crohn’s disease after failure of anti-TNF agents: An observational comparative study design with a Bayesian analysis

Background: Crohn’s disease (CD) is a debilitating gastrointestinal disease with complex etiology. Although effective, recipients of anti-tumor necrosis factor (TNF) agents may experience primary or secondary nonresponse, necessitating alternative treatments. This study is intended to compare the sh...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ahmad Alamer, Lina H Al Lehaibi, Mukhtar Alomar, Fahad Aldhuwayan, Saleh Alshouish, Anfal Y Al-Ali, Zakia Almudhry, Abdulaziz Almulhim, Abdulhamid Althagafi, Saad Aldosari, Turki AlAmeel
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Medknow Publications 2024-09-01
Edice:	The Saudi Journal of Gastroenterology
Témata:	anti-tnf therapy biological therapy crohn’s disease effectiveness ustekinumab vedolizumab
On-line přístup:	https://journals.lww.com/sjga/fulltext/2024/30050/short_term_effectiveness_of_ustekinumab_versus.8.aspx
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!